KALU Q1 2026 Earnings Massive EPS Surprise of 97 Drives Stock Higher FSUN Q1 2026 Earnings EPS Falls Short of Analyst Expectations Shares Edge Lower Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29 FRME Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges BATRK Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline